STRS Ohio’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-38,600
Closed -$2.02M 2371
2020
Q3
$2.02M Sell
38,600
-3,600
-9% -$149K 0.01% 636
2020
Q2
$1.4M Sell
42,200
-1,500
-3% -$47.8K 0.01% 737
2020
Q1
$1.19M Buy
+43,700
New +$1.22M 0.01% 669
2019
Q2
Sell
-12,400
Closed -$180K 2256
2019
Q1
$180K Sell
12,400
-14,300
-54% -$183K ﹤0.01% 1703
2018
Q4
$294K Hold
26,700
﹤0.01% 1515
2018
Q3
$702K Hold
26,700
﹤0.01% 1154
2018
Q2
$546K Sell
26,700
-28,500
-52% -$612K ﹤0.01% 1321
2018
Q1
$1M Sell
55,200
-600
-1% -$10K ﹤0.01% 861
2017
Q4
$778K Hold
55,800
﹤0.01% 1021
2017
Q3
$1.03M Buy
55,800
+2,900
+5% +$48.5K ﹤0.01% 844
2017
Q2
$894K Buy
52,900
+36,300
+219% +$553K ﹤0.01% 884
2017
Q1
$221K Buy
+16,600
New +$260K ﹤0.01% 1514
2016
Q2
Sell
-15,800
Closed -$145K 2047
2016
Q1
$145K Sell
15,800
-21,400
-58% -$230K ﹤0.01% 1582
2015
Q4
$552K Buy
+37,200
New +$622K ﹤0.01% 1241
2014
Q2
Sell
-48,900
Closed -$570K 1798
2014
Q1
$570K Sell
48,900
-228,018
-82% -$3.86M ﹤0.01% 1107
2013
Q4
$4.9M Sell
276,918
-138,090
-33% -$2.32M 0.02% 482
2013
Q3
$5.97M Hold
415,008
0.03% 477
2013
Q2
$6.25M Buy
+415,008
New +$5.48M 0.03% 472

STRS Ohio's MNTA Position: Q4 2020 in Review

STRS Ohio sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 38,600 shares — an estimated $2.02M sold.

STRS Ohio first reported a position in MNTA in Q2 2013 and held it in 18 quarters. The position peaked at $6.25M in Q2 2013. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • STRS Ohio reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 38,600 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.02M.
  • STRS Ohio first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • STRS Ohio's Momenta Pharmaceuticals, Inc. position peaked at $6.25M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.